{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:33:03Z","timestamp":1762223583668,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002403","name":"Taibah University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108987","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:03:17Z","timestamp":1758020597000},"page":"108987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-scale investigation of PQ3-quinoxaline derivatives as selective COX-2 inhibitors: synthesis, structural analysis, DFT, MD simulations, and in silico\/in vitro evaluation"],"prefix":"10.1016","volume":"165","author":[{"given":"Fares Hezam","family":"Al-Ostoot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Akhileshwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek H.","family":"Kameshwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majed S.","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam Y.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shwetha H.","family":"Nanjundappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Chkirate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Van Meervelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem","family":"Abad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.108987_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357907.2024.2437614","article-title":"Chronic inflammation and Cancer: key pathways and targeted therapies","volume":"43","author":"Kapoor","year":"2025","journal-title":"Cancer Invest."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108987_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D3MD00511A","article-title":"Latest developments in coumarin-based anticancer agents: mechanism of action and structure\u2013activity relationship studies","volume":"15","author":"Koley","year":"2024","journal-title":"RSC Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108987_bb0015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/07357907.2024.2361295","article-title":"An overview of Cancer biology, pathophysiological development and it\u2019s treatment modalities: current challenges of Cancer anti-Angiogenic therapy","volume":"42","author":"Al-Ostoot","year":"2024","journal-title":"Cancer Invest."},{"key":"10.1016\/j.bioorg.2025.108987_bb0020","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s43440-021-00266-8","article-title":"Targeting HIF-1\u03b1 by newly synthesized Indolephenoxyacetamide (IPA) analogs to induce anti-angiogenesis-mediated solid tumor suppression","volume":"73","author":"Al-Ostoot","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108987_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fonc.2020.00409","article-title":"Shedding new light on cancer metabolism: a metabolic tightrope between life and death","volume":"31","author":"L\u00e4sche","year":"2020","journal-title":"Front. Oncol."},{"issue":"28","key":"10.1016\/j.bioorg.2025.108987_bb0030","article-title":"Tumor angiogenesis: current challenges and therapeutic opportunities","volume":"1","author":"Al-Ostoot","year":"2021","journal-title":"Cancer Treatment Res. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108987_bb0035","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3390\/cancers16061216","article-title":"Reviewing the landscape of cancer survivorship: insights from Dr. Lidia Schapira\u2019s Programs and Beyond","volume":"16","author":"Cortiana","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108987_bb0040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1021\/acsptsci.4c00008","article-title":"Advances in precision medicine approaches for colorectal cancer: from molecular profiling to targeted therapies","volume":"7","author":"Kiran","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108987_bb0045","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/14737140.2019.1631800","article-title":"The role of combination chemo-immunotherapy in advanced non-small cell lung cancer","volume":"19","author":"Rocco","year":"2019","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108987_bb0050","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108987_bb0055","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3987\/COM-22-14668","article-title":"Synthesis and enzyme inhibitory properties of quinoxaline-bridged bis(imidazolium) salts","volume":"104","author":"Yi\u011fit","year":"2022","journal-title":"Heterocycles"},{"issue":"1232","key":"10.1016\/j.bioorg.2025.108987_bb0060","article-title":"Synthesis, crystal structure, DFT calculations, Hirshfeld surface analysis, energy frameworks, molecular dynamics and docking studies of novel isoxazolequinoxaline derivative (IZQ) as anti-cancer drug","volume":"15","author":"Abad","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"276","key":"10.1016\/j.bioorg.2025.108987_bb0065","article-title":"Exploring quinoxaline derivatives: an overview of a new approach to combat antimicrobial resistance","volume":"5","author":"Khatoon","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1321","key":"10.1016\/j.bioorg.2025.108987_bb0070","article-title":"Molecular drug design, theoretical, experimental approaches and new framework of novel oxazol dihydroquinoxaline (ODQ): efficient synthesis, crystallographic, computational investigation, DFT calculation, ADME analysis and antiangiogenic molecular docking","volume":"5","author":"Abad","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108987_bb0075","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.3390\/molecules25122784","article-title":"Quinoxaline derivatives as antiviral agents: a systematic review","volume":"25","author":"Montana","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108987_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2023.100783","article-title":"Analgesic and anti-inflammatory activity of quinoxaline derivatives: design synthesis and characterization","volume":"5","author":"Meka","year":"2023","journal-title":"Results Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108987_bb0085","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.ejca.2008.05.018","article-title":"A phase I and pharmacokinetic study of the quinoxaline antitumour agent R (+) XK469 in patients with advanced solid tumours","volume":"44","author":"Undevia","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108987_bb0090","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1007\/s11696-024-03485-4","article-title":"Noncovalent interactions between quinoxalines and protoporphyrinogen oxidase (PPO): a computational case study for herbicidal applications","volume":"78","author":"Hajji","year":"2024","journal-title":"Chem. Pap."},{"issue":"1286","key":"10.1016\/j.bioorg.2025.108987_bb0095","article-title":"Synthesis, non-covalent interactions and chemical reactivity of 1-pentyl-3-phenylquinoxalin-2 (1H)-one\u2014structural and computational studies","author":"Abad","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108987_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/ncrs-2020-0404","article-title":"Synthesis and crystal structure of 1-octyl-3-phenylquinoxalin-2 (1H)-one, C22H26N2O","volume":"236","author":"Abad","year":"2021","journal-title":"Zeitschrift f\u00fcr Kristallographie-New Crystal Structures."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108987_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Foundations Crystallogr.."},{"issue":"s1","key":"10.1016\/j.bioorg.2025.108987_bb0110","article-title":"PLATON, an integrated tool for the analysis of the results of a single crystal structure determination","volume":"46","author":"Spek","year":"1990","journal-title":"Foundations Crystallogr."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108987_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","article-title":"Mercury 4.0: from visualization to analysis, design and prediction","volume":"53","author":"Macrae","year":"2020","journal-title":"Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.108987_bb0120","first-page":"150","article-title":"gaussian 09, Gaussian. Inc","volume":"121","author":"Frisch","year":"2009","journal-title":"Wallingford CT."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108987_bb0125","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1063\/1.1446025","article-title":"Accurate core electron binding energy calculations using small 6-31G and TZV core hole optimized basis sets","volume":"116","author":"Carniato","year":"2002","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2025.108987_bb0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1874104501206010015","article-title":"Virtual screening for finding novel COX-2 inhibitors as antitumor agents","volume":"6","author":"Badieyan","year":"2012","journal-title":"Open Med Chem J"},{"key":"10.1016\/j.bioorg.2025.108987_bb0135","doi-asserted-by":"crossref","unstructured":"H.K. Keerthy, H.K. Vivek, H. Bharathkumar, S. Rangappa, K.C. Bulusu, L.H. Mervin, J.E. Fuchs, B.S. Priya, Basappa, N. Swamy S, A. Bender, K.S. Rangappa, MOLPRINT 2D-based identification and synthesis of novel chromene based small molecules that target PLA2: validation through chemo- and bioinformatics approaches, RSC Advances 5(109) (2015) 89797\u201389808.","DOI":"10.1039\/C5RA13085A"},{"key":"10.1016\/j.bioorg.2025.108987_bb0140","doi-asserted-by":"crossref","unstructured":"P.H. M, F.H. Al-Ostoot, V. Hamse Kameshwar, H. Khamees, S.A. Khanum, Design, synthesis, characterization, docking studies of novel 4-phenyl acrylamide-1,3-thiazole derivatives as anti-inflammatory and anti-ulcer agents, J. Mol. Struct. 1292 (2023) 136126.","DOI":"10.1016\/j.molstruc.2023.136126"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108987_bb0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/chromsci\/bmab102","article-title":"Enantiomeric separation of Indole-3-Propanamide derivatives by using supercritical fluid chromatography on a polysaccharide-based chiral stationary phase","volume":"60","author":"Suryakoppa","year":"2021","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.bioorg.2025.108987_bb0150","doi-asserted-by":"crossref","unstructured":"P.H. M, F.H. Al-Ostoot, H.K. Vivek, S.A. Khanum, Synthesis, characterization, DFT, docking studies and molecular dynamics of some 3-phenyl-5-furan isoxazole derivatives as anti-inflammatory and anti-ulcer agents, J. Mol. Struct. 1250 (2022) 131812.","DOI":"10.1016\/j.molstruc.2021.131812"},{"key":"10.1016\/j.bioorg.2025.108987_bb0155","doi-asserted-by":"crossref","unstructured":"B. Dhanalakshmi, A.K.B. Motatis, S.M. Venkatappan, S.S. Muddenahalli, V.H. Kameshwar, S. Madhappan, S. and Rangappa, Design, synthesis and docking studies of novel 4-aminophenol-1,2,4-oxadiazole hybrids as apoptosis inducers against triple negative breast cancer cells targeting MAP kinase, J. Biomol. Struct. Dyn. 42(11) (2024) 5841\u20135857.","DOI":"10.1080\/07391102.2023.2239912"},{"issue":"11","key":"10.1016\/j.bioorg.2025.108987_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21312","article-title":"Synthesis, crystal structure, DFT, Hirshfeld surface analysis, energy frameworks and in-silico drug-targeting PFKFB3 kinase of novel triazolequinoxalin derivative (TZQ) as a therapeutic strategy against cancer","volume":"9","author":"Abad","year":"2023","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108987_bb0165","first-page":"1037","article-title":"Crystal structure, Hirshfeld surface analysis and density functional theory study of 1-nonyl-3-phenylquinoxalin-2-one","volume":"77","author":"Abad","year":"2021","journal-title":"Struct. Rep."},{"key":"10.1016\/j.bioorg.2025.108987_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133107","article-title":"Insight into structural features and supramolecular architecture of synthesized quinoxaline derivatives with anti-leishmanial activity, in vitro","volume":"1263","author":"Kumar","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"40","key":"10.1016\/j.bioorg.2025.108987_bb0175","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/D1CE00878A","article-title":"Isostructurality of quinoxaline crystal phases: the interplay of weak hydrogen bonds and halogen bonding","volume":"23","author":"Saidykhan","year":"2021","journal-title":"CrystEngComm"},{"key":"10.1016\/j.bioorg.2025.108987_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127244","article-title":"Design-based synthesis, molecular docking analysis of an anti-inflammatory drug, and geometrical optimization and interaction energy studies of an indole acetamide derivative","volume":"1202","author":"Al-Ostoot","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108987_bb0185","doi-asserted-by":"crossref","DOI":"10.1107\/S0108767306098199","article-title":"CrystalExplorer: a tool for displaying Hirshfeld surfaces and visualising intermolecular interactions in molecular crystals","volume":"62","author":"Jayatilaka","year":"2006","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.bioorg.2025.108987_bb0190","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1039\/b704980c","article-title":"Towards quantitative analysis of intermolecular interactions with Hirshfeld surfaces","volume":"37","author":"McKinnon","year":"2007","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108987_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10870-022-00959-9","article-title":"Crystal structure characterization, interaction energy analysis and DFT studies of 3-(4-Chlorophenyl)-N-phenylquinoxalin-2-amine","volume":"53","author":"Akhileshwari","year":"2023","journal-title":"J. Chem. Crystallogr."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108987_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33814","article-title":"Structural and theoretical exploration of a multi-methoxy chalcone: synthesis, quantum theory, electrostatics, molecular packing, DFT analysis, and in-silico anti-cancer evaluation","volume":"10","author":"Al-Ostoot","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2025.108987_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02708340","article-title":"Chemical hardness and density functional theory","volume":"117","author":"Pearson","year":"2005","journal-title":"J. Chem. Sci."},{"issue":"1244","key":"10.1016\/j.bioorg.2025.108987_bb0210","article-title":"Synthesis, crystal structure, Hirshfeld surface analysis, DFT calculations, 3D energy frameworks studies of Schiff base derivative 2, 2\u2032-((1Z, 1\u2032 Z)-(1, 2-phenylene bis (azanylylidene)) bis (methanylylidene)) diphenol","author":"Chandini","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108987_bb0215","doi-asserted-by":"crossref","unstructured":"P.H. M, F.H. Al-Ostoot, H.K. Vivek, S.A. Khanum, Design, docking, synthesis, and characterization of novel N'(2-phenoxyacetyl) nicotinohydrazide and N'(2-phenoxyacetyl)isonicotinohydrazide derivatives as anti-inflammatory and analgesic agents, J. Mol. Struct. 1247 (2022) 131404.","DOI":"10.1016\/j.molstruc.2021.131404"},{"issue":"46","key":"10.1016\/j.bioorg.2025.108987_bb0220","doi-asserted-by":"crossref","first-page":"45763","DOI":"10.1074\/jbc.M305481200","article-title":"A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385","volume":"278","author":"Rowlinson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.bioorg.2025.108987_bb0225","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1021\/acs.biochem.9b00659","article-title":"Arg-513 and Leu-531 are key residues governing time-dependent inhibition of Cyclooxygenase-2 by aspirin and Celebrex","volume":"58","author":"Dong","year":"2019","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108987_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08204","article-title":"Impact of non-covalent interactions on FT-IR spectrum and properties of 4-methylbenzylammonium nitrate. A DFT and molecular docking study","volume":"7","author":"Medimagh","year":"2021","journal-title":"Heliyon"},{"issue":"1250","key":"10.1016\/j.bioorg.2025.108987_bb0235","article-title":"Deciphering non-covalent interactions of 1, 3-Benzenedimethanaminium bis (trioxonitrate): synthesis, empirical and computational study","author":"Gatfaoui","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108987_bb0240","doi-asserted-by":"crossref","unstructured":"Ramalingam A, Kuppusamy M, Sambandam S, Medimagh M, Oyeneyin OE, Shanmugasundaram A, Issaoui N, Ojo ND. Synthesis, spectroscopic, topological, hirshfeld surface analysis, and anti-covid-19 molecular docking investigation of isopropyl 1-benzoyl-4-(benzoyloxy)-2, vols. 6-diphenyl-1, 2, 5, 6-tetrahydropyridine-3-carboxylate. Heliyon. 2022 Oct 1;8(10).","DOI":"10.1016\/j.heliyon.2022.e10831"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108987_bb0245","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.3390\/molecules28062684","article-title":"Molecular structure, electronic properties, reactivity (ELF, LOL, and Fukui), and NCI-RDG studies of the binary mixture of water and essential oil of Phlomis bruguieri","volume":"28","author":"Akman","year":"2023","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.bioorg.2025.108987_bb0250","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1055\/s-0042-1751526","article-title":"Recent advances in the multicomponent synthesis of heterocycles using 5-aminotetrazole","volume":"56","author":"Javahershenas","year":"2024","journal-title":"Synthesis"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108987_bb0255","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discovery"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108987_bb0260","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00044-020-02528-1","article-title":"Selective cyclooxygenase-2 inhibitors: a review of recent chemical scaffolds with promising anti-inflammatory and COX-2 inhibitory activities","volume":"29","author":"Mohsin","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108987_bb0265","first-page":"64","article-title":"Molecular basis of binding interactions of NSAIDs and computer-aided drug design approaches in the pursuit of the development of cyclooxygenase-2 (COX-2) selective inhibitors","volume":"2","author":"Deb","year":"2017","journal-title":"Nonsteroidal Anti-Inflamm. Drugs"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108987_bb0270","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:28:16Z","timestamp":1762223296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":54,"alternative-id":["S0045206825008673"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108987","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-scale investigation of PQ3-quinoxaline derivatives as selective COX-2 inhibitors: synthesis, structural analysis, DFT, MD simulations, and in silico\/in vitro evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108987"}}